109 related articles for article (PubMed ID: 27870946)
21. Clonal heterogeneity and chromosomal instability at disease presentation in high hyperdiploid acute lymphoblastic leukemia.
Talamo A; Chalandon Y; Marazzi A; Jotterand M
Cancer Genet Cytogenet; 2010 Dec; 203(2):209-14. PubMed ID: 21156235
[TBL] [Abstract][Full Text] [Related]
22. High hyperdiploid childhood acute lymphoblastic leukemia.
Paulsson K; Johansson B
Genes Chromosomes Cancer; 2009 Aug; 48(8):637-60. PubMed ID: 19415723
[TBL] [Abstract][Full Text] [Related]
23. Aleukaemic leukaemia presenting with pathological fracture.
Chua GT; Chow KC; So JC; Cheuk DK
BMJ Case Rep; 2014 Jul; 2014():. PubMed ID: 24990848
[TBL] [Abstract][Full Text] [Related]
24. Aberrations of chromosomes 9 and 22 in acute lymphoblastic leukemia cases detected by ES-fluorescence in situ hybridization.
Cetin Z; Yakut S; Karadogan I; Kupesiz A; Timuragaoglu A; Salim O; Tezcan G; Alanoglu G; Ozbalci D; Hazar V; Yesilipek MA; Undar L; Luleci G; Berker S
Genet Test Mol Biomarkers; 2012 May; 16(5):318-23. PubMed ID: 22360868
[TBL] [Abstract][Full Text] [Related]
25. High modal number and triple trisomies are highly correlated favorable factors in childhood B-cell precursor high hyperdiploid acute lymphoblastic leukemia treated according to the NOPHO ALL 1992/2000 protocols.
Paulsson K; Forestier E; Andersen MK; Autio K; Barbany G; Borgström G; Cavelier L; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kjeldsen E; Nordgren A; Palmqvist L; Johansson B; ; ;
Haematologica; 2013 Sep; 98(9):1424-32. PubMed ID: 23645689
[TBL] [Abstract][Full Text] [Related]
26. Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia.
Ramos-Muntada M; Trincado JL; Blanco J; Bueno C; Rodríguez-Cortez VC; Bataller A; López-Millán B; Schwab C; Ortega M; Velasco P; Blanco ML; Nomdedeu J; Ramírez-Orellana M; Minguela A; Fuster JL; Cuatrecasas E; Camós M; Ballerini P; Escherich G; Boer J; DenBoer M; Hernández-Rivas JM; Calasanz MJ; Cazzaniga G; Harrison CJ; Menéndez P; Molina O
Mol Oncol; 2022 Aug; 16(16):2899-2919. PubMed ID: 35726693
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of chromosome aberrations in childhood acute lymphoid leukemia (ALL).
Balogh E; Oláh E; Kovács I
Acta Paediatr Hung; 1990; 30(2):271-89. PubMed ID: 2248806
[TBL] [Abstract][Full Text] [Related]
28. Lineage classification of childhood acute lymphoblastic leukemia according to the EGIL recommendations: results of the ALL-BFM 2000 trial.
Ratei R; Schabath R; Karawajew L; Zimmermann M; Möricke A; Schrappe M; Ludwig WD
Klin Padiatr; 2013 May; 225 Suppl 1():S34-9. PubMed ID: 23700065
[TBL] [Abstract][Full Text] [Related]
29. Cytogenetic Profile of De Novo B lineage Acute Lymphoblastic Leukemia: Determination of Frequency, Distribution Pattern and Identification of Rare and Novel Chromosomal Aberrations in Indian Patients.
Bhandari P; Ahmad F; Dalvi R; Koppaka N; Kokate P; Das BR; Mandava S
Asian Pac J Cancer Prev; 2015; 16(16):7219-29. PubMed ID: 26514515
[TBL] [Abstract][Full Text] [Related]
30. Immunophenotypic Characterization of Cytogenetic Subgroups in Egyptian Pediatric Patients With B-Cell Acute Lymphoblastic Leukemia.
Adnan Awad S; Kamel MM; Ayoub MA; Kamel AM; Elnoshokaty EH; El Hifnawi N
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S19-S24.e1. PubMed ID: 27521317
[TBL] [Abstract][Full Text] [Related]
31. Detection of dicentric chromosome (9;20) in paediatric B-cell acute lymphoblastic leukaemia: prognostic significance.
Letouzey M; Penther D; Roche-Lestienne C; Nelken B; Devoldère C; Vannier JP; Schneider P
Ann Hematol; 2015 Feb; 94(2):187-93. PubMed ID: 25193356
[TBL] [Abstract][Full Text] [Related]
32. Incidence and relevance of secondary chromosome abnormalities in childhood TEL/AML1+ acute lymphoblastic leukemia: an interphase FISH analysis.
Attarbaschi A; Mann G; König M; Dworzak MN; Trebo MM; Mühlegger N; Gadner H; Haas OA;
Leukemia; 2004 Oct; 18(10):1611-6. PubMed ID: 15356655
[TBL] [Abstract][Full Text] [Related]
33. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
[TBL] [Abstract][Full Text] [Related]
34. Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19).
Raimondi SC; Behm FG; Roberson PK; Williams DL; Pui CH; Crist WM; Look AT; Rivera GK
J Clin Oncol; 1990 Aug; 8(8):1380-8. PubMed ID: 2380759
[TBL] [Abstract][Full Text] [Related]
35. Isolated del(14)(q21) in a case of precursor B-cell acute lymphoblastic leukemia.
Meloni-Ehrig AM; Tirado CA; Chen K; Jahn J; Suchan S; Scheerle J; Crosby MG; Meany H; Seibel N; Leitenberg D; Heritage DW; Mowrey PN
Cancer Genet Cytogenet; 2005 Aug; 161(1):82-5. PubMed ID: 16080963
[TBL] [Abstract][Full Text] [Related]
36. Secondary acute myelogenous leukemia (AML) with trisomy 10 and del(9q) following precursor B-cell acute lymphoblastic leukemia (ALL) with a hyperdiploid karyotype.
Al-Tahou K; Jamil S; Mody R; Knaus A; Micale M; Huang J
Cancer Genet; 2012 Oct; 205(10):533-6. PubMed ID: 22944559
[TBL] [Abstract][Full Text] [Related]
37. Centrosome Aberration Frequency and Disease Association in B-Acute Lymphoblastic Leukemia.
Kerketta LS; Ghosh K; Nadkarni A; Madkaikar M; Vundinti BR
In Vivo; 2017; 31(2):215-220. PubMed ID: 28358703
[TBL] [Abstract][Full Text] [Related]
38. Biological and clinical significance of cytogenetic study on 100 acute lymphoblastic leukemia and 219 acute non-lymphoblastic leukemia.
Ye J; Cao Q; Su X; Huang Q; Ma Z; Wang Z; Huang W; Chen Z; Chen S
Chin Med J (Engl); 1997 Feb; 110(2):90-5. PubMed ID: 9594276
[TBL] [Abstract][Full Text] [Related]
39. CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol.
Ghazavi F; Clappier E; Lammens T; Suciu S; Caye A; Zegrari S; Bakkus M; Grardel N; Benoit Y; Bertrand Y; Minckes O; Costa V; Ferster A; Mazingue F; Plat G; Plouvier E; Poirée M; Uyttebroeck A; van der Werff-Ten Bosch J; Yakouben K; Helsmoortel H; Meul M; Van Roy N; Philippé J; Speleman F; Cavé H; Van Vlierberghe P; De Moerloose B
Haematologica; 2015 Oct; 100(10):1311-9. PubMed ID: 26137961
[TBL] [Abstract][Full Text] [Related]
40. PRAME overexpression predicted good outcome in pediatric B-cell acute lymphoblastic leukemia patients receiving chemotherapy.
Zhang YH; Lu AD; Yang L; Li LD; Chen WM; Long LY; Zhang LP; Qin YZ
Leuk Res; 2017 Jan; 52():43-49. PubMed ID: 27875783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
